Abstract
Endometrial cancer has generally a good prognosis when it is diagnosed at an early stage but remains incurable at an advanced stage (recurrent or metastatic) with only few therapeutic options. Hormone therapy is the treatment of choice in case of slowly progressive disease with a tumor expressing hormonal receptors due to its favorable safety profile. Taxanes, anthracyclines and platinum compounds are the most active chemotherapy agents with greater response rates when they are combined at the price of a significant toxicity. Targeted therapies based on a better understanding of tumor biology are being evaluated with some promising results.
| Translated title of the contribution | Systemic therapy for advanced endometrial cancer |
|---|---|
| Original language | French |
| Pages (from-to) | 93-97 |
| Number of pages | 5 |
| Journal | Bulletin du Cancer |
| Volume | 99 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2012 |